ORIG3N Lands $5,105,000 New Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a6be3a18-3bd0-4b52-a5c6-ed9baf3af071 - Date
12/9/2015 - Company Name
ORIG3N - Mailing Address
27 Drydock Ave. 6th Floor Boston, MA 02210 USA - Company Description
Boston based ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases with targets in heart, liver and neurodegenerative indications. These treatments are based upon Nobel Prize winning technology. - Website
http://www.orig3n.com - Transaction Type
Venture Equity - Transaction Amount
$5,105,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. - M&A Terms
- Venture Investor
Undisclosed
